Astellas doubles down on gene therapy with $3bn Audentes deal
05-12-2019
Roche buys fibrotic diseases biotech in $1.4bn deal
19-11-2019
Catalent to buy $1.2bn gene therapy company
17-04-2019
Roche to pay $2.4bn for remainder of Foundation Medicine
20-06-2018
Roche to make $1.9bn acquisition
19-02-2018